Related references
Note: Only part of the references are listed.Divergence in the approach to tumor necrosis factor α-inhibitor recipients with coccidioidomycosis
Ashley L. Garrett et al.
INFECTION (2017)
Single-center experience of antifungal prophylaxis for coccidioidomycosis in heart transplant recipients within an endemic area
Graham M. Lohrmann et al.
TRANSPLANT INFECTIOUS DISEASE (2017)
Approach to Management of Coccidioidomycosis in Patients Receiving Inhibitors of Tumor Necrosis Factor-α
Janis E. Blair et al.
INFECTIOUS DISEASES IN CLINICAL PRACTICE (2017)
Coccidioidomycosis Transmission Through Organ Transplantation: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee
S. Kusne et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
John N. Galgiani et al.
CLINICAL INFECTIOUS DISEASES (2016)
Donor-Derived Coccidioides immitis Endocarditis and Disseminated Infection in the Setting of Solid Organ Transplantation
Joanna K. Nelson et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis
Neil M. Ampel et al.
CLINICAL AND VACCINE IMMUNOLOGY (2015)
Histoplasmosis Complicating Tumor Necrosis Factor-alpha Blocker Therapy: A Retrospective Analysis of 98 Cases
Paschalis Vergidis et al.
CLINICAL INFECTIOUS DISEASES (2015)
Universal Fungal Prophylaxis and Risk of Coccidioidomycosis in Liver Transplant Recipients Living in an Endemic Area
Allon Kahn et al.
LIVER TRANSPLANTATION (2015)
Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation
N. Mendoza et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
The Utility of Diagnostic Testing for Active Coccidioidomycosis in Solid Organ Transplant Recipients
N. Mendoza et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Immunological Characterization of Bronchoalveolar Lavage Fluid in Patients With Acute Pulmonary Coccidioidomycosis
Lance A. Nesbit et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Antiretroviral Therapy-associated Coccidioidal Meningitis
Ronald Trible et al.
EMERGING INFECTIOUS DISEASES (2013)
Donor-Derived Fungal Infections in Organ Transplant Recipients: Guidelines of the American Society of Transplantation, Infectious Diseases Community of Practice
N. Singh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Coccidioidomycosis of cervical lymph nodes in an HIV-infected patient with immunologic reconstitution on potent HAART: a rare observation in a nonendemic area
Alessandro D'Avino et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Donor-derived Coccidioides immitis fungemia in solid organ transplant recipients
E. Blodget et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Donor-derived organ transplant transmission of coccidioidomycosis
K. L. Dierberg et al.
TRANSPLANT INFECTIOUS DISEASE (2012)
Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs
Sara Taroumian et al.
ARTHRITIS CARE & RESEARCH (2012)
Coccidioidomycosis in Liver Transplant Recipients in an Endemic Area
D. Vucicevic et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Interleukin-12 Receptor β1 Deficiency Predisposing to Disseminated Coccidioidomycosis
Donald C. Vinh et al.
CLINICAL INFECTIOUS DISEASES (2011)
Reactivation of Coccidioidomycosis Despite Antifungal Prophylaxis in Solid Organ Transplant Recipients
David W. Keckich et al.
TRANSPLANTATION (2011)
Coccidioidomycosis in Patients with HIV-1 Infection in the Era of Potent Antiretroviral Therapy
Fares Y. Masannat et al.
CLINICAL INFECTIOUS DISEASES (2010)
Tumor necrosis factor antagonists: Different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infection
Daniel E. Furst et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2006)
Coccidioidomycosis in hematopoietic stem cell transplant recipients
TJ Glenn et al.
MEDICAL MYCOLOGY (2005)
Coccidioidomycosis: Host response and vaccine development
RA Cox et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists
L Bergstrom et al.
ARTHRITIS AND RHEUMATISM (2004)
Posttransplantation disseminated coccidioidomycosis acquired from donor lungs
MB Miller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects
JH Rex et al.
CLINICAL INFECTIOUS DISEASES (2003)
Donor-related coccidioidomycosis in organ transplant recipients
PW Wright et al.
CLINICAL INFECTIOUS DISEASES (2003)
Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept
JH Lee et al.
ARTHRITIS AND RHEUMATISM (2002)
Donor transfer of pulmonary coccidioidomycosis in lung transplantation
U Tripathy et al.
ANNALS OF THORACIC SURGERY (2002)
Coccidioidomycosis in solid organ transplantation
JE Blair et al.
CLINICAL INFECTIOUS DISEASES (2001)
Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: Incidence, risk factors, and prevention
CW Woods et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
